13-Feb-2026
Nu Skin Earnings Call: Profits Rise, Outlook Cautious
TipRanks (Sat, 14-Feb 7:03 PM ET)
Benzinga (Fri, 13-Feb 8:03 AM ET)
Top 3 Defensive Stocks That May Rocket Higher In February
Benzinga (Fri, 13-Feb 6:01 AM ET)
Nu Skin Stock Sinks After Weak Quarter, Soft Outlook
Benzinga (Fri, 13-Feb 5:47 AM ET)
Seeking Alpha News (Thu, 12-Feb 9:35 PM ET)
Nu Skin declares $0.06 dividend
Seeking Alpha News (Thu, 12-Feb 4:29 PM ET)
Nu Skin GAAP EPS of $0.29 misses by $0.01, revenue of $370.3M misses by $12.4M
Seeking Alpha News (Thu, 12-Feb 4:20 PM ET)
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Business Wire (Thu, 12-Feb 4:06 PM ET)
Nu Skin Enterprises Announces Quarterly Dividend
Business Wire (Thu, 12-Feb 4:05 PM ET)
Nu Skin Q4 2025 Earnings Preview
Seeking Alpha News (Wed, 11-Feb 5:35 PM ET)
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Nu Skin Enterprises trades on the NYSE stock market under the symbol NUS.
As of February 13, 2026, NUS stock price declined to $8.36 with 1,693,727 million shares trading.
NUS has a beta of 1.44, meaning it tends to be more sensitive to market movements. NUS has a correlation of 0.15 to the broad based SPY ETF.
NUS has a market cap of $407.55 million. This is considered a Small Cap stock.
Last quarter Nu Skin Enterprises reported $370 million in Revenue and $.29 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.01.
In the last 3 years, NUS traded as high as $45.55 and as low as $5.32.
The top ETF exchange traded funds that NUS belongs to (by Net Assets): FNDA, AVUV, VTI, IWM, VDC.
NUS has outperformed the market in the last year with a return of +34.0%, while the SPY ETF gained +13.0%. However, in the most recent history, NUS shares have underperformed the stock market with its stock returning -13.9% in the last 3 month period and -21.2% for the last 2 week period, while SPY has returned +1.7% and -1.5%, respectively.
NUS support price is $9.89 and resistance is $10.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUS shares will trade within this expected range on the day.